$ALPN Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in ALPINE IMMUNE SCIENCES, INC..

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview

Overview of all insider trading transactions in ALPINE IMMUNE SCIENCES, INC.. Get notifications about new insider transactions in ALPINE IMMUNE SCIENCES, INC. for free.

Page: 1 2 next >

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Jun 29 2021	ALPN	ALPINE IMMUNE SCIE ...	GOLD MITCHELL	Executive Chairman ...	Sell	S	10.00	3,479	34,792	164,901	168.4 K to 164.9 K (-2.07 %)
Jun 29 2021	ALPN	ALPINE IMMUNE SCIE ...	GOLD MITCHELL	Executive Chairman ...	Sell	S	10.01	9,473	94,865	168,380	177.9 K to 168.4 K (-5.33 %)
May 21 2021	ALPN	ALPINE IMMUNE SCIE ...	GOLD MITCHELL	Executive Chairman ...	Sell	S	15.00	1,221	18,316	177,853	179.1 K to 177.9 K (-0.68 %)
May 21 2021	ALPN	ALPINE IMMUNE SCIE ...	GOLD MITCHELL	Executive Chairman ...	Sell	S	15.03	50,965	765,917	179,074	230 K to 179.1 K (-22.15 %)
May 14 2021	ALPN	ALPINE IMMUNE SCIE ...	GOLD MITCHELL	Executive Chairman ...	Sell	S	11.52	10,000	115,169	230,039	240 K to 230 K (-4.17 %)
May 14 2021	ALPN	ALPINE IMMUNE SCIE ...	GOLD MITCHELL	Executive Chairman ...	Sell	S	11.68	10,000	116,842	240,039	250 K to 240 K (-4.00 %)
Apr 23 2021	ALPN	ALPINE IMMUNE SCIE ...	Venkatesan Jay	Director	Option Exercise	M	3.62	7,650	27,718	0
Apr 23 2021	ALPN	ALPINE IMMUNE SCIE ...	Venkatesan Jay	Director	Option Exercise	M	4.09	7,650	31,289	0
Apr 23 2021	ALPN	ALPINE IMMUNE SCIE ...	Venkatesan Jay	Director	Buy	M	3.62	7,650	27,718	218,063	210.4 K to 218.1 K (+3.64 %)
Apr 23 2021	ALPN	ALPINE IMMUNE SCIE ...	Venkatesan Jay	Director	Buy	M	4.09	7,650	31,289	210,413	202.8 K to 210.4 K (+3.77 %)
Apr 15 2021	ALPN	ALPINE IMMUNE SCIE ...	GOLD MITCHELL	Executive Chairman ...	Sell	S	10.52	10,000	105,200	250,039	260 K to 250 K (-3.85 %)
Apr 15 2021	ALPN	ALPINE IMMUNE SCIE ...	GOLD MITCHELL	Executive Chairman ...	Sell	S	10.07	10,000	100,714	260,039	270 K to 260 K (-3.70 %)
Mar 08 2021	ALPN	ALPINE IMMUNE SCIE ...	GOLD MITCHELL	Executive Chairman ...	Sell	S	12.99	10,000	129,875	270,039	280 K to 270 K (-3.57 %)
Mar 08 2021	ALPN	ALPINE IMMUNE SCIE ...	GOLD MITCHELL	Executive Chairman ...	Sell	S	13.01	10,000	130,108	280,039	290 K to 280 K (-3.45 %)
Feb 03 2021	ALPN	ALPINE IMMUNE SCIE ...	GOLD MITCHELL	Executive Chairman ...	Sell	S	11.74	10,000	117,381	290,039	300 K to 290 K (-3.33 %)
Feb 03 2021	ALPN	ALPINE IMMUNE SCIE ...	GOLD MITCHELL	Executive Chairman ...	Sell	S	13.20	7,021	92,698	300,039	307.1 K to 300 K (-2.29 %)
Feb 03 2021	ALPN	ALPINE IMMUNE SCIE ...	GOLD MITCHELL	Executive Chairman ...	Sell	S	12.07	2,979	35,968	307,060	310 K to 307.1 K (-0.96 %)
Jan 06 2021	ALPN	ALPINE IMMUNE SCIE ...	Rickey James Paul	Senior VP and CFO	Option Exercise	A	13.20	120,000	1,584,000	120,000
Jan 06 2021	ALPN	ALPINE IMMUNE SCIE ...	GOLD MITCHELL	Executive Chairman ...	Option Exercise	A	13.20	255,000	3,366,000	255,000
Jan 06 2021	ALPN	ALPINE IMMUNE SCIE ...	PENG STANFORD L	See Remarks	Option Exercise	A	13.20	150,000	1,980,000	150,000
Jan 04 2021	ALPN	ALPINE IMMUNE SCIE ...	PENG STANFORD L	See Remarks	Payment of Exercise	F	12.60	3,923	49,430	24,371	28.3 K to 24.4 K (-13.87 %)
Jan 04 2021	ALPN	ALPINE IMMUNE SCIE ...	GOLD MITCHELL	Executive Chairman ...	Payment of Exercise	F	12.60	11,123	140,150	310,039	321.2 K to 310 K (-3.46 %)
Jan 04 2021	ALPN	ALPINE IMMUNE SCIE ...	Rickey James Paul	Senior VP and CFO	Payment of Exercise	F	12.60	2,258	28,451	24,027	26.3 K to 24 K (-8.59 %)
Dec 30 2020	ALPN	ALPINE IMMUNE SCIE ...	ORBIMED ADVISORS LLC	Director	Sell	S	14.25	600,000	8,550,000	3,070,955	3.7 M to 3.1 M (-16.34 %)
Dec 30 2020	ALPN	ALPINE IMMUNE SCIE ...	Thompson Peter A.	Director	Sell	S	14.25	600,000	8,550,000	3,070,955	3.7 M to 3.1 M (-16.34 %)
Dec 22 2020	ALPN	ALPINE IMMUNE SCIE ...	GOLD MITCHELL	Executive Chairman ...	Buy	J	0.00	260,528	0	321,162	60.6 K to 321.2 K (+429.67 %)
Dec 22 2020	ALPN	ALPINE IMMUNE SCIE ...	GOLD MITCHELL	Executive Chairman ...	Sell	J	0.00	993,801	0	3,000,980	4 M to 3 M (-24.88 %)
Dec 22 2020	ALPN	ALPINE IMMUNE SCIE ...	Alpine ImmunoSciences, L.P.	10% Owner	Sell	J	0.00	993,801	0	3,000,980	4 M to 3 M (-24.88 %)
Dec 22 2020	ALPN	ALPINE IMMUNE SCIE ...	Venkatesan Jay	Director	Buy	J	0.00	181,024	0	202,763	21.7 K to 202.8 K (+832.72 %)
Dec 22 2020	ALPN	ALPINE IMMUNE SCIE ...	Venkatesan Jay	Director	Sell	J	0.00	993,801	0	3,000,980	4 M to 3 M (-24.88 %)
Dec 11 2020	ALPN	ALPINE IMMUNE SCIE ...	Hernday Natasha	Director	Option Exercise	A	11.07	15,000	166,050	15,000
Nov 23 2020	ALPN	ALPINE IMMUNE SCIE ...	CONWAY ROBERT E	Director	Buy	P	8.03	10,000	80,300	25,000	15 K to 25 K (+66.67 %)
Jul 09 2020	ALPN	ALPINE IMMUNE SCIE ...	PENG STANFORD L	See Remarks	Option Exercise	A	7.20	50,000	360,000	50,000
Jul 01 2020	ALPN	ALPINE IMMUNE SCIE ...	Rickey James Paul	Senior VP and CFO	Payment of Exercise	F	9.71	2,258	21,925	26,285	28.5 K to 26.3 K (-7.91 %)
Jul 01 2020	ALPN	ALPINE IMMUNE SCIE ...	GOLD MITCHELL	Executive Chairman ...	Payment of Exercise	F	9.71	8,227	79,884	60,634	68.9 K to 60.6 K (-11.95 %)
Jul 01 2020	ALPN	ALPINE IMMUNE SCIE ...	PENG STANFORD L	See Remarks	Payment of Exercise	F	9.71	3,923	38,092	28,294	32.2 K to 28.3 K (-12.18 %)
Jan 27 2020	ALPN	ALPINE IMMUNE SCIE ...	Rickey James Paul	Senior VP and CFO	Option Exercise	A	3.23	102,000	329,460	102,000
Jan 27 2020	ALPN	ALPINE IMMUNE SCIE ...	Rickey James Paul	Senior VP and CFO	Grant	A	0.00	18,543	0	28,543	10 K to 28.5 K (+185.43 %)
Jan 27 2020	ALPN	ALPINE IMMUNE SCIE ...	PENG STANFORD L	President & Head of ...	Option Exercise	A	3.23	108,000	348,840	108,000
Jan 27 2020	ALPN	ALPINE IMMUNE SCIE ...	PENG STANFORD L	President & Head of ...	Grant	A	0.00	32,217	0	32,217	0 to 32.2 K
Jan 27 2020	ALPN	ALPINE IMMUNE SCIE ...	GOLD MITCHELL	Executive Chairman ...	Option Exercise	A	3.23	270,000	872,100	270,000
Jan 27 2020	ALPN	ALPINE IMMUNE SCIE ...	GOLD MITCHELL	Executive Chairman ...	Grant	A	0.00	67,569	0	68,861	1.3 K to 68.9 K (+5,229.80 %)
Jan 27 2020	ALPN	ALPINE IMMUNE SCIE ...	GOLD MITCHELL	Executive Chairman ...	Gift	G	0.00	5,000	0	1,292	6.3 K to 1.3 K (-79.47 %)
Jan 27 2020	ALPN	ALPINE IMMUNE SCIE ...	GOLD MITCHELL	Executive Chairman ...	Gift	G	0.00	5,000	0	6,292	11.3 K to 6.3 K (-44.28 %)
Jan 06 2020	ALPN	ALPINE IMMUNE SCIE ...	SEKHRI PAUL J	Director	Option Exercise	A	3.62	7,650	27,718	7,650
Jan 06 2020	ALPN	ALPINE IMMUNE SCIE ...	Peetz Christopher	Director	Option Exercise	A	3.62	7,650	27,718	7,650
Jan 06 2020	ALPN	ALPINE IMMUNE SCIE ...	Venkatesan Jay	Director	Option Exercise	A	3.62	7,650	27,718	7,650
Jan 06 2020	ALPN	ALPINE IMMUNE SCIE ...	CONWAY ROBERT E	Director	Option Exercise	A	3.62	7,650	27,718	7,650
Jan 06 2020	ALPN	ALPINE IMMUNE SCIE ...	Cui Xiangmin	Director	Option Exercise	A	3.62	7,650	27,718	7,650
Jan 06 2020	ALPN	ALPINE IMMUNE SCIE ...	Thompson Peter A.	Director	Option Exercise	A	3.62	7,650	27,718	7,650
Jan 06 2020	ALPN	ALPINE IMMUNE SCIE ...	Topper James N	Director	Option Exercise	A	3.62	7,650	27,718	7,650
Jun 03 2019	ALPN	ALPINE IMMUNE SCIE ...	Rickey James Paul	Senior VP and CFO	Buy	P	4.95	10,000	49,500	10,000	0 to 10 K
Feb 12 2019	ALPN	ALPINE IMMUNE SCIE ...	TIGER MANAGEMENT L.L.C.	10% Owner	Sell	S	5.85	25,000	146,245	137,728	162.7 K to 137.7 K (-15.36 %)
Feb 08 2019	ALPN	ALPINE IMMUNE SCIE ...	Rickey James Paul	Senior VP and CFO	Option Exercise	A	6.51	75,000	488,250	75,000
Feb 08 2019	ALPN	ALPINE IMMUNE SCIE ...	GOLD MITCHELL	Executive Chairman ...	Option Exercise	A	6.51	200,000	1,302,000	200,000
Feb 08 2019	ALPN	ALPINE IMMUNE SCIE ...	Litton Mark James	See Remarks	Option Exercise	A	6.51	75,000	488,250	75,000
Feb 08 2019	ALPN	ALPINE IMMUNE SCIE ...	Litton Mark James	See Remarks	Option Exercise	A	6.81	25,000	170,250	25,000
Feb 08 2019	ALPN	ALPINE IMMUNE SCIE ...	PENG STANFORD L	See Remarks	Option Exercise	A	6.51	75,000	488,250	75,000
Jan 23 2019	ALPN	ALPINE IMMUNE SCIE ...	Thompson Peter A.	Director	Option Exercise	P	0.00	145,251	0	145,251
Jan 23 2019	ALPN	ALPINE IMMUNE SCIE ...	Thompson Peter A.	Director	Buy	P	5.37	372,439	1,999,997	3,670,955	3.3 M to 3.7 M (+11.29 %)
Jan 23 2019	ALPN	ALPINE IMMUNE SCIE ...	ORBIMED ADVISORS LLC	Director	Option Exercise	P	0.00	145,251	0	145,251
Jan 23 2019	ALPN	ALPINE IMMUNE SCIE ...	ORBIMED ADVISORS LLC	Director	Buy	P	5.37	372,439	1,999,997	3,670,955	3.3 M to 3.7 M (+11.29 %)
Jan 23 2019	ALPN	ALPINE IMMUNE SCIE ...	Cui Xiangmin	Director	Option Exercise	A	5.70	7,650	43,611	7,650
Jan 23 2019	ALPN	ALPINE IMMUNE SCIE ...	Cui Xiangmin	Director	Option Exercise	A	12.74	1,234,636	15,729,263	1,234,636
Jan 23 2019	ALPN	ALPINE IMMUNE SCIE ...	Cui Xiangmin	Director	Grant	A	5.37	3,165,735	16,999,997	3,165,735	0 to 3.2 M
Jan 23 2019	ALPN	ALPINE IMMUNE SCIE ...	Cui Xiangmin	Director	Option Exercise	A	5.70	7,650	43,611	7,650
Jan 23 2019	ALPN	ALPINE IMMUNE SCIE ...	Cui Xiangmin	Director	Option Exercise	A	12.74	1,234,636	15,729,263	1,234,636
Jan 23 2019	ALPN	ALPINE IMMUNE SCIE ...	Cui Xiangmin	Director	Grant	A	5.37	3,165,735	16,999,997	3,165,735	0 to 3.2 M
Jan 22 2019	ALPN	ALPINE IMMUNE SCIE ...	Alpine ImmunoSciences, L.P.	10% Owner	Option Exercise	P	12.74	74,441	948,378	74,441
Jan 22 2019	ALPN	ALPINE IMMUNE SCIE ...	Alpine ImmunoSciences, L.P.	10% Owner	Option Exercise	P	12.74	74,441	948,378	74,441
Jan 22 2019	ALPN	ALPINE IMMUNE SCIE ...	Alpine ImmunoSciences, L.P.	10% Owner	Buy	P	5.37	190,875	1,024,999	3,994,781	3.8 M to 4 M (+5.02 %)
Jan 22 2019	ALPN	ALPINE IMMUNE SCIE ...	Alpine ImmunoSciences, L.P.	10% Owner	Buy	P	5.37	190,875	1,024,999	3,994,781	3.8 M to 4 M (+5.02 %)
Jan 22 2019	ALPN	ALPINE IMMUNE SCIE ...	GOLD MITCHELL	Executive Chairman ...	Option Exercise	P	12.74	74,441	948,378	74,441
Jan 22 2019	ALPN	ALPINE IMMUNE SCIE ...	GOLD MITCHELL	Executive Chairman ...	Option Exercise	P	12.74	74,441	948,378	74,441
Jan 22 2019	ALPN	ALPINE IMMUNE SCIE ...	GOLD MITCHELL	Executive Chairman ...	Gift	G	0.00	6,000	0	11,292	17.3 K to 11.3 K (-34.70 %)
Jan 22 2019	ALPN	ALPINE IMMUNE SCIE ...	GOLD MITCHELL	Executive Chairman ...	Gift	G	0.00	6,000	0	11,292	17.3 K to 11.3 K (-34.70 %)
Jan 22 2019	ALPN	ALPINE IMMUNE SCIE ...	GOLD MITCHELL	Executive Chairman ...	Gift	G	0.00	3,000	0	17,292	20.3 K to 17.3 K (-14.78 %)
Jan 22 2019	ALPN	ALPINE IMMUNE SCIE ...	GOLD MITCHELL	Executive Chairman ...	Gift	G	0.00	3,000	0	17,292	20.3 K to 17.3 K (-14.78 %)
Jan 22 2019	ALPN	ALPINE IMMUNE SCIE ...	GOLD MITCHELL	Executive Chairman ...	Gift	G	0.00	3,000	0	20,292	23.3 K to 20.3 K (-12.88 %)
Jan 22 2019	ALPN	ALPINE IMMUNE SCIE ...	GOLD MITCHELL	Executive Chairman ...	Gift	G	0.00	3,000	0	20,292	23.3 K to 20.3 K (-12.88 %)
Jan 22 2019	ALPN	ALPINE IMMUNE SCIE ...	GOLD MITCHELL	Executive Chairman ...	Buy	P	5.37	190,875	1,024,999	3,994,781	3.8 M to 4 M (+5.02 %)
Jan 22 2019	ALPN	ALPINE IMMUNE SCIE ...	GOLD MITCHELL	Executive Chairman ...	Buy	P	5.37	190,875	1,024,999	3,994,781	3.8 M to 4 M (+5.02 %)
Jan 22 2019	ALPN	ALPINE IMMUNE SCIE ...	Venkatesan Jay	Director	Option Exercise	P	12.74	74,441	948,378	74,441
Jan 22 2019	ALPN	ALPINE IMMUNE SCIE ...	Venkatesan Jay	Director	Option Exercise	P	12.74	74,441	948,378	74,441
Jan 22 2019	ALPN	ALPINE IMMUNE SCIE ...	Venkatesan Jay	Director	Buy	P	5.37	190,875	1,024,999	3,994,781	3.8 M to 4 M (+5.02 %)
Jan 22 2019	ALPN	ALPINE IMMUNE SCIE ...	Venkatesan Jay	Director	Buy	P	5.37	190,875	1,024,999	3,994,781	3.8 M to 4 M (+5.02 %)
Jan 22 2019	ALPN	ALPINE IMMUNE SCIE ...	Frazier Life Sciences VIII, L. ...	10% Owner	Option Exercise	P	12.74	145,251	1,850,498	145,251
Jan 22 2019	ALPN	ALPINE IMMUNE SCIE ...	Frazier Life Sciences VIII, L. ...	10% Owner	Buy	P	5.37	372,439	1,999,997	2,571,450	2.2 M to 2.6 M (+16.94 %)
Jan 22 2019	ALPN	ALPINE IMMUNE SCIE ...	Topper James N	Director	Option Exercise	P	12.74	145,251	1,850,498	145,251
Jan 22 2019	ALPN	ALPINE IMMUNE SCIE ...	Topper James N	Director	Buy	P	5.37	372,439	1,999,997	2,571,450	2.2 M to 2.6 M (+16.94 %)
Jan 04 2019	ALPN	ALPINE IMMUNE SCIE ...	Topper James N	Director	Option Exercise	A	4.09	7,650	31,289	7,650
Jan 04 2019	ALPN	ALPINE IMMUNE SCIE ...	CONWAY ROBERT E	Director	Option Exercise	A	4.09	7,650	31,289	7,650
Jan 04 2019	ALPN	ALPINE IMMUNE SCIE ...	Venkatesan Jay	Director	Option Exercise	A	4.09	7,650	31,289	7,650
Jan 04 2019	ALPN	ALPINE IMMUNE SCIE ...	Thompson Peter A.	Director	Option Exercise	A	4.09	7,650	31,289	7,650
Jan 04 2019	ALPN	ALPINE IMMUNE SCIE ...	Peetz Christopher	Director	Option Exercise	A	4.09	7,650	31,289	7,650
Jan 04 2019	ALPN	ALPINE IMMUNE SCIE ...	SEKHRI PAUL J	Director	Option Exercise	A	4.09	7,650	31,289	7,650
Oct 02 2018	ALPN	ALPINE IMMUNE SCIE ...	PENG STANFORD L	See Remarks	Option Exercise	A	6.33	250,000	1,582,500	250,000
Aug 08 2018	ALPN	ALPINE IMMUNE SCIE ...	Litton Mark James	See Remarks	Option Exercise	A	6.81	150,000	1,021,500	150,000
Apr 24 2018	ALPN	ALPINE IMMUNE SCIE ...	Peetz Christopher	Director	Option Exercise	A	7.91	7,650	60,512	7,650
Jan 04 2018	NVLS	ALPINE IMMUNE SCIE ...	Topper James N	Director	Option Exercise	A	11.31	7,650	86,522	7,650
Jan 04 2018	NVLS	ALPINE IMMUNE SCIE ...	SEKHRI PAUL J	Director	Option Exercise	A	11.31	7,650	86,522	7,650
Jan 04 2018	NVLS	ALPINE IMMUNE SCIE ...	Rickey James Paul	Senior VP and CFO	Option Exercise	A	11.31	45,000	508,950	45,000
Jan 04 2018	NVLS	ALPINE IMMUNE SCIE ...	GOLD MITCHELL	Executive Chairman ...	Option Exercise	A	11.31	70,000	791,700	70,000
Jan 04 2018	NVLS	ALPINE IMMUNE SCIE ...	CONWAY ROBERT E	Director	Option Exercise	A	11.31	7,650	86,522	7,650
Jan 04 2018	NVLS	ALPINE IMMUNE SCIE ...	Venkatesan Jay	President	Option Exercise	A	11.31	25,000	282,750	25,000
Jan 04 2018	NVLS	ALPINE IMMUNE SCIE ...	PENG STANFORD L	See Remarks	Option Exercise	A	11.31	65,000	735,150	65,000
Jan 04 2018	NVLS	ALPINE IMMUNE SCIE ...	Thompson Peter A.	Director	Option Exercise	A	11.31	7,650	86,522	7,650
Jul 26 2017	NVLS	ALPINE IMMUNE SCIE ...	Thompson Peter A.	Director	Grant	A	0.00	3,298,516	0	3,298,516	0 to 3.3 M
Jul 26 2017	NVLS	ALPINE IMMUNE SCIE ...	GOLD MITCHELL	Executive Chairman ...	Option Exercise	A	5.02	208,916	1,048,758	208,916
Jul 26 2017	NVLS	ALPINE IMMUNE SCIE ...	GOLD MITCHELL	Executive Chairman ...	Option Exercise	A	0.65	300,624	195,406	300,624
Jul 26 2017	NVLS	ALPINE IMMUNE SCIE ...	GOLD MITCHELL	Executive Chairman ...	Option Exercise	A	0.45	51,242	23,059	51,242
Jul 26 2017	NVLS	ALPINE IMMUNE SCIE ...	GOLD MITCHELL	Executive Chairman ...	Buy	J	0.00	3,803,906	0	3,803,906	0 to 3.8 M
Jul 26 2017	NVLS	ALPINE IMMUNE SCIE ...	GOLD MITCHELL	Executive Chairman ...	Grant	A	0.00	23,292	0	23,292	0 to 23.3 K
Jul 26 2017	NVLS	ALPINE IMMUNE SCIE ...	GOLD MITCHELL	Executive Chairman ...	Buy	J	0.00	24,845	0	24,845	0 to 24.8 K
Jul 26 2017	NVLS	ALPINE IMMUNE SCIE ...	GOLD MITCHELL	Executive Chairman ...	Buy	J	0.00	24,845	0	24,845	0 to 24.8 K
Jul 26 2017	NVLS	ALPINE IMMUNE SCIE ...	GOLD MITCHELL	Executive Chairman ...	Buy	J	0.00	24,845	0	24,845	0 to 24.8 K
Jul 26 2017	NVLS	ALPINE IMMUNE SCIE ...	PENG STANFORD L	See Remarks	Option Exercise	A	0.65	37,267	24,224	37,267
Jul 26 2017	NVLS	ALPINE IMMUNE SCIE ...	PENG STANFORD L	See Remarks	Option Exercise	A	0.65	161,492	104,970	161,492
Jul 26 2017	NVLS	ALPINE IMMUNE SCIE ...	ORBIMED ADVISORS LLC	Director	Grant	A	0.00	3,298,516	0	3,298,516	0 to 3.3 M
Jul 26 2017	NVLS	ALPINE IMMUNE SCIE ...	Topper James N	Director	Grant	A	0.00	2,199,011	0	2,199,011	0 to 2.2 M
Jul 26 2017	NVLS	ALPINE IMMUNE SCIE ...	Rickey James Paul	Senior VP and CFO	Option Exercise	A	5.02	74,535	374,166	74,535
Jul 26 2017	NVLS	ALPINE IMMUNE SCIE ...	Venkatesan Jay	President	Option Exercise	A	0.45	90,063	40,528	90,063
Jul 26 2017	NVLS	ALPINE IMMUNE SCIE ...	Venkatesan Jay	President	Buy	J	0.00	3,803,906	0	3,803,906	0 to 3.8 M
Jul 26 2017	NVLS	ALPINE IMMUNE SCIE ...	Venkatesan Jay	President	Grant	A	0.00	21,739	0	21,739	0 to 21.7 K
Jul 26 2017	NVLS	ALPINE IMMUNE SCIE ...	Venkatesan Jay	President	Buy	J	0.00	18,633	0	18,633	0 to 18.6 K
Jul 26 2017	NVLS	ALPINE IMMUNE SCIE ...	Venkatesan Jay	President	Buy	J	0.00	18,633	0	18,633	0 to 18.6 K
Jun 22 2017	NVLS	Nivalis Therapeuti ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.25	1,715	3,859	201,811	200.1 K to 201.8 K (+0.86 %)
Jun 22 2017	NVLS	Nivalis Therapeuti ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.25	6,359	14,308	717,089	710.7 K to 717.1 K (+0.89 %)
Jun 22 2017	NVLS	Nivalis Therapeuti ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.25	9,732	21,897	1,109,258	1.1 M to 1.1 M (+0.89 %)
Jun 07 2017	NVLS	Nivalis Therapeuti ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.28	3,673	8,379	200,096	196.4 K to 200.1 K (+1.87 %)
Jun 07 2017	NVLS	Nivalis Therapeuti ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.28	13,046	29,762	710,730	697.7 K to 710.7 K (+1.87 %)
Jun 07 2017	NVLS	Nivalis Therapeuti ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.28	20,181	46,039	1,099,526	1.1 M to 1.1 M (+1.87 %)
Jun 07 2017	NVLS	Nivalis Therapeuti ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.29	3,920	8,979	196,423	192.5 K to 196.4 K (+2.04 %)
Jun 07 2017	NVLS	Nivalis Therapeuti ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.29	12,624	28,917	697,684	685.1 K to 697.7 K (+1.84 %)
Jun 07 2017	NVLS	Nivalis Therapeuti ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.29	19,206	43,993	1,079,345	1.1 M to 1.1 M (+1.81 %)
Jun 01 2017	NVLS	Nivalis Therapeuti ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.25	2,727	6,128	192,503	189.8 K to 192.5 K (+1.44 %)
Jun 01 2017	NVLS	Nivalis Therapeuti ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.25	10,023	22,522	685,060	675 K to 685.1 K (+1.48 %)
Jun 01 2017	NVLS	Nivalis Therapeuti ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.25	15,350	34,491	1,060,139	1 M to 1.1 M (+1.47 %)
Jun 01 2017	NVLS	Nivalis Therapeuti ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.30	1,805	4,144	189,776	188 K to 189.8 K (+0.96 %)
Jun 01 2017	NVLS	Nivalis Therapeuti ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.30	6,903	15,847	675,037	668.1 K to 675 K (+1.03 %)
Jun 01 2017	NVLS	Nivalis Therapeuti ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.30	10,192	23,398	1,044,789	1 M to 1 M (+0.99 %)
May 19 2017	NVLS	Nivalis Therapeuti ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.30	1,124	2,585	187,971	186.8 K to 188 K (+0.60 %)
May 19 2017	NVLS	Nivalis Therapeuti ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.30	4,223	9,713	668,134	663.9 K to 668.1 K (+0.64 %)
May 19 2017	NVLS	Nivalis Therapeuti ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.30	6,253	14,382	1,034,597	1 M to 1 M (+0.61 %)
May 19 2017	NVLS	Nivalis Therapeuti ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.30	2,909	6,690	186,847	183.9 K to 186.8 K (+1.58 %)
May 19 2017	NVLS	Nivalis Therapeuti ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.30	10,541	24,242	663,911	653.4 K to 663.9 K (+1.61 %)
May 19 2017	NVLS	Nivalis Therapeuti ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.30	16,436	37,800	1,028,344	1 M to 1 M (+1.62 %)
May 19 2017	NVLS	Nivalis Therapeuti ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.30	5,510	12,666	183,938	178.4 K to 183.9 K (+3.09 %)
May 19 2017	NVLS	Nivalis Therapeuti ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.30	6,897	15,854	653,370	646.5 K to 653.4 K (+1.07 %)
May 19 2017	NVLS	Nivalis Therapeuti ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.30	24,965	57,387	1,011,908	986.9 K to 1 M (+2.53 %)

Page: 1 2 next >